Physician

Colby Shane Brownlee, D.O.

According to 2025 Medicare claims, Colby Brownlee, D.O. (NPI: 1114289329) practices ophthalmology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is RONALD W. INGRAM, MD PA (NPI: 1043341811; TIN: 752773461) and primary practice location at 79701-3885.

Brownlee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,067 traditional Medicare patients, billed 4,263 HCPCS/CPT codes, and received $455,284 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 5,596 prescription claims across 971 beneficiaries totaling $295,359 in drug costs, led by Vyzulta (Latanoprostene Bunod). Open Payments data shows 9 records totaling $237. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $54,114 to $455,284. Similarly, Part D prescription costs have risen steadily, from $10,731 to $295,359. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$228K$455K2016 Medicare payment: $54,114 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $210,584 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $309,764 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $368,122 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $362,270 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $414,749 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $413,925 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $407,570 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $455,284 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016181539$54,114
20176071,946$210,584
20189222,909$309,764
20199013,501$368,122
20209323,556$362,270
20219883,992$414,749
20221,0224,188$413,925
20231,0214,091$407,570
20241,0674,263$455,284

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$168K$335K2015 Drug cost: $10,731 (USD; Tot_Drug_Cst)2016 Drug cost: $14,170 (USD; Tot_Drug_Cst)2017 Drug cost: $124,645 (USD; Tot_Drug_Cst)2018 Drug cost: $187,612 (USD; Tot_Drug_Cst)2019 Drug cost: $225,411 (USD; Tot_Drug_Cst)2020 Drug cost: $225,759 (USD; Tot_Drug_Cst)2021 Drug cost: $293,302 (USD; Tot_Drug_Cst)2022 Drug cost: $297,678 (USD; Tot_Drug_Cst)2023 Drug cost: $335,032 (USD; Tot_Drug_Cst)2024 Drug cost: $295,359 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201529142$10,731
201667178$14,170
20172851,295$124,645
20183961,990$187,612
20194962,411$225,411
20205472,738$225,759
20217383,807$293,302
20229214,718$297,678
20239294,993$335,032
20249715,596$295,359

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens317534$338
92004New patient complete exam of visual system409409$89
92012Established patient problem focused exam of visual system325546$59
92025Ct scan of cornea266275$24
92136Measurement of corneal curvature and depth of eye4371,295$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyzultaLatanoprostene Bunod1275,337$51,020
LumiganBimatoprost773,458$31,475
RocklatanNetarsudil Mesylat/Latanoprost692,568$31,061
RhopressaNetarsudil Mesylate752,701$29,389
Prednisolone AcetatePrednisolone Acetate1,01328,057$28,981

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$237ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Colby Shane Brownlee, D.O.?

Tedicare shows public-source Medicare data for Colby Shane Brownlee, D.O. (NPI 1114289329), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Colby Shane Brownlee, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Colby Shane Brownlee, D.O.?

Colby Shane Brownlee, D.O. is linked to RONALD W. INGRAM, MD PA (billing NPI 1043341811) in the available physician profile data.

Does Colby Shane Brownlee, D.O. have Open Payments data?

Colby Shane Brownlee, D.O. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.